SCHEMBL4433940

SCHEMBL4433940

COc1ccnc(C(C(C)=O)c2ccc(C(F)(F)F)cc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.42
KDR P35968 1/20 0.40
CLK2 P49760 1/20 0.40
IRAK1 P51617 1/20 0.40
NEK4 P51957 1/20 0.40
MAP4K2 Q12851 1/20 0.40
HIPK4 Q8NE63 1/20 0.40
SRPK1 Q96SB4 1/20 0.40
CLK4 Q9HAZ1 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
MAP3K20 Q9NYL2 1/20 0.40
STK17A Q9UEE5 1/20 0.40
MAP4K5 Q9Y4K4 1/20 0.40
AHR P35869 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
GSK3A P49840 1/20 0.39
GSK3B P49841 1/20 0.39
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4438360 0.79 SORT1 (0.46) BCHEKDRAHRAKR1C3AKR1C2
SCHEMBL4434012 0.73 TRPM8 (0.42) AHRNFE2L2
SCHEMBL4434628 0.72 AKR1C3 (0.51) MEN1KMT2AAKR1C3AKR1C2PDE2A
SCHEMBL4432946 0.72 FFAR1 (0.42) KMT2AGSK3BAKR1C3AKR1C2PDE2A
SCHEMBL29276323 0.72 MAPT (0.38) BCHEMEN1KMT2AAKR1C3AKR1C2
SCHEMBL28251775 0.70 TSHR (0.56) AHRMEN1KMT2A
SCHEMBL4441781 0.70 MEN1 (0.41) MEN1KMT2AAKR1C3AKR1C2PDE2A
SCHEMBL4435069 0.70 CES2 (0.41) GSK3BAKR1C3AKR1C2
SCHEMBL4432350 0.69 AKR1C3 (0.45) AKR1C3AKR1C2GPR139
SCHEMBL4430480 0.69 AKR1C3 (0.48) MEN1KMT2AAKR1C3AKR1C2CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114867-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. Hoffmann-Roche AG (CH) 2009-11-11 EP disclosed
WO-2008107335-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-09-12 WO disclosed